Researched by Industrial Info Resources (Sugar Land, Texas)--According to China's National Bureau of Statistics, in 2019, China's pharmaceutical capacity reached 2.769 million tons, with a year-over-year growth of 20.2%. In 2020, capacity was 2.734 million tons, a slight downturn attributed to the COVID-19 pandemic. The annual output of China's active pharmaceutical ingredients (APIs) stabilized at about »

Overall project spending has been roiled by the economic fallout from the COVID-19 pandemic and other factors. As of Thursday, Industrial Info was tracking $267 billion worth of project activity that has been affected by the coronavirus in North America, ranging from delays to cancellations. For January, the spending index totaled $704.15 billion, up 2.7% from $685.61 »

Project spending by the Industrial Manufacturing Industry took a dip in 2020 as the COVID-19 pandemic hit, but remained relatively robust and is only expected to increase in the next two years, according to David Pickering, Industrial Info's vice of president of research for the industry. About $25 billion of spending was delayed in early 2020 as coronavirus hit North »

Spending on pharmaceutical and biotech projects in North America will rise 1.4% this year from 2017, according to Industrial Info's 2018 Global Industrial Outlook. Annette Kreuger, Industrial Info's vice president of research for the Pharmaceutical-Biotech Industry, said, "An impact from favorable new tax laws is expected to boost capex investment, as more cash is readily available. New products »

Researched by Industrial Info Resources (Sugar Land, Texas)--The total pipeline of planned capital and maintenance project activity within the Metals & Minerals Industry being tracked by Industrial Info Resources stands at more than 15,900 projects valued at $1.68 trillion, according to the latest data presented at a recent outlook webinar conducted by Joe Govreau, vice president of »